Regular ArticleAutochthonous mouse models for prostate cancer: past, present and future
References (140)
Hormonal therapy in the management of prostate cancer: from Huggins to the present
Urology
(1997)- et al.
The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation
Cell
(1993) - et al.
Prostatic steroid-binding protein. Isolation and characterization of C3 genes
J Biol Chem
(1983) - et al.
Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. Fundamental role of an AP-1 element
J Biol Chem
(1994) - et al.
Sequences 5’ of the bovine keratin 5 gene direct tissue- and cell-type- specific expression of a lacZ gene in the adult and during development
Differentiation
(1994) - et al.
Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer
J Urol
(2000) A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer
Genomics
(1997)- et al.
Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas
Hum Pathol
(1996) - et al.
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells
Am J Pathol
(1998) - et al.
Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
Cell
(1995)
Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2
J Biol Chem
(1999)
Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer
J Biol Chem
(2001)
Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread
Hum Pathol
(1992)
Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
J Urol
(1974)
Histologic grading of prostate cancer: a perspective
Hum Pathol
(1992)
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
Urology
(2000)
The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer
J Urol
(1992)
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
J Urol
(1998)
Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate
J Urol
(1990)
Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis
J Urol
(1992)
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Cell
(1989)
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
J Urol
(1998)
Carcinoma of prostate: case against immediate hormonal therapy
Prostate
(1996)
Prostatic intraepithelial neoplasia: animal models 2000
Prostate
(2000)
Workgroup I: rodent models of prostate cancer
Prostate
(1998)
Workgroup 3: transgenic and reconstitution models of prostate cancer
Prostate
(1998)
Studying cancer in the mouse
Oncogene
(1999)
Molecular genetics of prostate cancer [in process citation]
Genes Dev
(2000)
Mouse models of prostate cancer
Oncogene
(1999)
Prostate cancer in a transgenic mouse
Proc Natl Acad Sci USA
(1995)
Cell alterations induced by the large T-antigens of SV40 and polyoma virus
Semin Cancer Biol
(1990)
Metastatic prostate cancer in a transgenic mouse
Cancer Res
(1996)
Pathologic progression of autochthonous prostate cancer in the TRAMP model
Prostate Cancer and Prostatic Diseases
(1999)
Androgen-independent prostate cancer progression in the TRAMP model
Cancer Research
(1997)
Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene
Proc Natl Acad Sci USA
(1994)
Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations
Cancer Res
(1996)
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer [corrected and republished article originally printed in Lab Invest 1998 Mar;78:319-333]
Lab Invest
(1998)
Cryptdins: endogenous antibiotic peptides of small intestinal Paneth cells
Adv Exp Med Biol
(1995)
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
Proc Natl Acad Sci USA
(1998)
Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice
Lab Invest
(1996)
Prostate cancer progression, metastasis, and gene expression in transgenic mice
Cancer Research
(1997)
RasT24 driven by a probasin promoter induces prostatic hyperplasia in transgenic mice
Transgenics
(1996)
Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein
Prostate
(2000)
Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia
Oncogene
(2000)
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor
Prostate
(2000)
Abnormal prostate development in C3(1)-bcl-2 transgenic mice
Prostate
(1997)
The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo
Oncogene
(2000)
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice
Proc Natl Acad Sci USA
(2000)
Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells
Proc Natl Acad Sci USA
(1990)
Genomic instability-based transgenic models of prostate cancer
Carcinogenesis
(2000)
Cited by (0)
- 1
Corresponding author. Email: [email protected]
Copyright © 2001 Academic Press. All rights reserved.